Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2XYU

Crystal structure of EphA4 kinase domain in complex with VUF 12058

Summary for 2XYU
Entry DOI10.2210/pdb2xyu/pdb
Related1B0X
DescriptorEPHRIN TYPE-A RECEPTOR 4,, GLYCEROL, 5-(5-FLUORO-2-METHYLPHENYL)-6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[3,4-C]ISOQUINOLIN-1-AMINE, ... (4 entities in total)
Functional Keywordssignaling protein, transferase
Biological sourceMUS MUSCULUS (MOUSE)
Cellular locationCell membrane; Single-pass type I membrane protein: Q03137
Total number of polymer chains1
Total formula weight33081.23
Authors
Farenc, C.J.A.,Celie, P.H.N.,vanLinden, O.P.J.,Siegal, G. (deposition date: 2010-11-19, release date: 2011-11-30, Last modification date: 2023-12-20)
Primary citationVan Linden, O.P.,Farenc, C.J.A.,Zoutman, W.H.,Hameetman, L.,Wijtmans, M.,Leurs, R.,Tensen, C.P.,Siegal, G.,De Esch, I.J.
Fragment Based Lead Discovery of Small Molecule Inhibitors for the Epha4 Receptor Tyrosine Kinase.
Eur.J.Med.Chem., 47:493-, 2012
Cited by
PubMed Abstract: The in silico identification, optimization and crystallographic characterization of a 6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c]isoquinolin-1-amine scaffold as an inhibitor for the EPHA4 receptor tyrosine kinase is described. A database containing commercially available compounds was subjected to an in silico screening procedure which was focused on finding novel, EPHA4 hinge binding fragments. This resulted in the identification of 6,7,8,9-tetrahydro-3H-pyrazolo[3,4-c]isoquinolin-1-amine derivatives as EPHA4 inhibitors. Hit exploration yielded a compound with 2 μM (IC(50)) affinity for the EPHA4 receptor tyrosine kinase domain. Soaking experiments into a crystal of the EPHA4 kinase domain gave a 2.11Å X-ray structure of the EPHA4 - inhibitor complex, which confirmed the binding mode of the scaffold as proposed by the initial in silico work. The results underscore the strength of fragment based in silico screening as a tool for the discovery of novel lead compounds as small molecule kinase inhibitors.
PubMed: 22137457
DOI: 10.1016/J.EJMECH.2011.11.020
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.117 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon